Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells

Clinical trial NCT04628806 · UNKNOWN

Trial details

NCT number: NCT04628806
Sponsor: Charite University, Berlin, Germany
Status: UNKNOWN
Study type: OBSERVATIONAL

Melanoma Stage IV Sarcoma Squamous Cell Carcinoma Pancreatic Cancer Stage IV Prostate Cancer Breast Cancer Stage IV

Start date: 2021-02-17
Primary completion: 2022-02-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.